Apyx Medical (APYX) Osake Kurssi
Apyx Medical Kurssi
Viimeisten 19 vuoden aikana Apyx Medicaln liikevaihto kasvoi 3,7 % vuodessa ja ylsi 52,84 M USD:een. Osakekohtainen tulos on kasvanut 23,5 % vuodessa viimeisten 12 vuoden aikana. Apyx Medicaln nettomarginaali −21,2 % on noussut verrattuna −31,3 %:iin muutama vuosi sitten. Apyx Medicaln 12 kuukauden konsensustavoitehinta on 6,50 USD, noin yli kurssia 150,0 %. 12 analyytikosta 11 suosittaa ostoa — kokonaiskonsensus on Osta.
Apyx Medical osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Apyx Medical liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Apyx Medical -osakkeesta
Apyx Medical Corp is a medical technology company focused on developing and commercializing innovative thermal surgical solutions. The company's business model revolves around the development, manufacturing, and sale of advanced energy surgical devices. Apyx Medical Corp's flagship product, J-Plasma®, utilizes a helium plasma technology to provide precise tissue cutting, coagulation, and ablation with reduced thermal spread. This cutting-edge technology is widely used in various surgical specialties, including gynecology, dermatology, and plastic surgery. Apyx Medical Corp aims to provide healthcare professionals with state-of-the-art solutions that enhance patient safety, improve outcomes, and optimize surgical procedures.
Apyx Medical Corp is primarily active in the medical technology industry. As a leading provider of innovative surgical solutions, Apyx Medical Corp focuses on advancing the field of cosmetic and surgical procedures. With their cutting-edge technology and expertise, they cater to a wide range of medical specialties including plastic surgery, dermatology, and gynecology. By offering high-quality products and groundbreaking technologies, Apyx Medical Corp plays a significant role in enhancing patient outcomes and revolutionizing the way surgical procedures are performed.
The main competitors of Apyx Medical Corp in the market include companies such as Medtronic, ConMed Corporation, and Ethicon. These companies also operate in the medical device industry, offering similar products and solutions. Apyx Medical Corp faces competition in areas like electrosurgery systems, advanced energy surgical devices, and cosmetic surgery and dermatology solutions, among others. It is important for investors and stakeholders to be aware of the competitive landscape in order to analyze market dynamics, evaluate company performance, and make informed decisions regarding Apyx Medical Corp.
Apyx Medical Corp, formerly known as Bovie Medical Corporation, is a leading medical technology company that develops and markets innovative energy-based surgical solutions. With a rich history dating back to its founding in 1926, Apyx Medical Corp has continuously evolved to become a global provider of cutting-edge medical devices used in various medical specialties. The company's dedication to research and development has resulted in the creation of advanced products like J-Plasma®, a low-temperature plasma technology used in surgical and aesthetic procedures. Apyx Medical Corp strives to deliver superior medical solutions, improving patient outcomes and advancing the field of healthcare worldwide.
Apyx Medical Corp, a leading medical technology company, has accomplished several significant milestones. The company launched its flagship product, Renuvion, a revolutionary device used for precision surgery in aesthetic and cosmetic procedures. Apyx Medical Corp also expanded its global footprint by securing regulatory approvals in key markets worldwide, including the European Union and Canada. The company's dedication to innovation and excellence led to multiple prestigious awards and recognition, highlighting its position as a market leader. Additionally, Apyx Medical Corp successfully established strategic partnerships with renowned healthcare institutions, fostering collaborative research and development initiatives. With these achievements, Apyx Medical Corp solidifies its reputation as a trailblazer in the medical technology industry.
Apyx Medical Corp is primarily present in the United States.
Apyx Medical Corp represents a set of core values and corporate philosophy that are integral to their mission. The company is committed to delivering innovative energy-based technologies for various surgical specialties, including cosmetic surgery and gynecology. Apyx Medical Corp focuses on providing safe, reliable, and effective solutions to healthcare professionals, ensuring patient satisfaction and well-being. With a dedication to continuous improvement and excellence, Apyx Medical Corp aims to advance medical advancements and elevate patient care standards. By prioritizing quality, innovation, and customer needs, Apyx Medical Corp remains a trusted leader in the medical aesthetics industry.
Analyytikot asettavat tällä hetkellä Apyx Medical-osakkeelle keskimääräisen tavoitehinnan 6,50 USD (mediaani: 6,50 USD), mikä merkitsee +150,0 % viimeisimpään hintaan verrattuna. Konsensus perustuu 12 analyytikkoarvioon.
12 analyytikkoa arvioi tällä hetkellä Apyx Medical-osaketta: 11 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Apyx Medical-yhtiöltä 59,41 M USD liikevaihtoa ja −0,22 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Apyx Medical-osake noteerataan hintaan 2,33 EUR (2,60 USD).
Apyx Medical-osake (APYX) on listattuna 3 pörssissä, muun muassa: NASDAQ (APYX), Frankfurt (BOV.F), München (BOV.MU).
The Apyx Medical Corp is an internationally operating company that specializes in the development and marketing of innovative medical products. Its business model is focused on supporting doctors and medical facilities in improving clinical outcomes while optimizing patient results. The company specializes in three main areas: surgery, dermatology and aesthetics, and veterinary medicine. In surgery, the company offers innovative solutions to support operations. It utilizes ultrasound-based technology to make these processes faster, more precise, and safer. One of its most well-known products is the J-Plasma system, used in plastic surgery operations. This is a surgical instrument that allows doctors to perform precise incisions while minimizing bleeding and scarring. In dermatology and aesthetics, Apyx Medical provides solutions for skin treatment and improving outward appearance. One of its flagship products is the Renuvion J-Plasma handpiece, used in both dermatology and plastic surgery. This handpiece generates a plasma beam that rejuvenates the skin and reduces wrinkles. Additionally, Apyx Medical Corp also offers IPL systems, laser devices, and other tools for treating various skin conditions and removing hair and tattoos. Veterinary medicine is another important sector for the company. Apyx Medical provides solutions to improve animal treatment. The company has extensive experience in developing medical devices and instruments used in the veterinary field. These products are tailored to the needs of veterinarians and clinics, including surgical instruments, laser devices, and other tools for animal treatment. The business model of Apyx Medical Corp is based on the combination of research, development, and sales of innovative medical products. The company emphasizes close collaboration with doctors, clinics, and research institutions to understand customer needs and develop innovative solutions. Patient safety and health are at the forefront of the company's priorities. Apyx Medical Corp has a strong market presence in the United States, Europe, and Asia and aims to offer its customers innovative and high-quality solutions worldwide. The company continuously invests in research and development to expand its portfolio of innovative products and services and provide its customers with the best possible quality. In summary, the business model of Apyx Medical Corp aims to support clinical practice through the development and marketing of innovative medical products. The company offers solutions in three main areas: surgery, dermatology and aesthetics, and veterinary medicine. Close collaboration with customers and investment in research and development are key elements of this business model.
odotettu liikevaihto Apyx Medical on 59,41 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Apyx Medical on −9,42 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Apyx Medical:n hinta-voitto-suhde (P/E) on tällä hetkellä −11,64. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Apyx Medical-osakkeen arvostusta.
Apyx Medical:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,85. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Apyx Medical-osakkeen arvostuskennuslukuna.
Apyx Medical:n Eulpool-laatuscore on 5/10.
Apyx Medical:n ISIN on US03837C1062. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Apyx Medical:n WKN on A2PBJC. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Apyx Medical:n ticker on APYX. Tämä pörssinoteeraus käytetään Apyx Medical-osakkeiden kauppaan pörssissä.
Apyx Medical osake
Apyx Medical vertaisryhmä
Apyx Medical Ticker
Apyx Medical FIGI
Kaikki tunnusluvut ja syvällinen analyysi Apyx Medical:sta
Meidän osakeanalyysimme Apyx Medical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Apyx Medical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: